Opendata, web and dolomites


Suppresion of adaptive immunity by the Salmonella effector SteD

Total Cost €


EC-Contrib. €






 SupaSteD project word cloud

Explore the words cloud of the SupaSteD project. It provides you a very rough idea of what is the project "SupaSteD" about.

first    therapeutic    found    encoded    pathogen    mrc    influence    indicating    leader    significantly    molecular    sted    onset    acute    fever    mutant    levels    vivo    typhimurium    college    antigen    additional    delta    model    pathogenicity    bacteriology    acid    chronic    secretion    virulence    formulations    wild    thereby    mhcii    bacterial    localised    holden    explore    causing    imperial    supervisor    variation    preliminary    cmbi    delayed    c57bl    dendritic    immune    typhoid    newly    centre    prof    models    class    cell    london    human    amino    spi    mechanistic    immunity    natural    significance    pathogenesis    effector    serovars    histocompatibility    vaccines    paratyphi    functions    mature    infection    physiological    broad    mice    director    island    gene    manipulation    clinical    serovar    cells    modulator    showing    salmonella    group    chance    t3ss    surface    globally    world    activation    enterica    sequence    stm    typhi    dna    mouse    adaptive    presenting    pathogens    reduces   

Project "SupaSteD" data sheet

The following table provides information about the project.


Organization address
city: LONDON
postcode: SW7 2AZ

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website
 Total cost 195˙454 €
 EC max contribution 195˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-09-01   to  2019-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

In this project, I propose to characterize the influence of SteD, an effector of a globally important bacterial pathogen Salmonella enterica, on T cell development, and its potential therapeutic application. In the mouse model of S. enterica infection, the onset of the specific immune responses is delayed significantly in comparison to other bacterial pathogens. Recent work by the group of Prof. Holden, who is the supervisor of this project, a world leader in the field of Salmonella pathogenesis and the Director of the MRC Centre for Molecular Bacteriology and Infection (MRC-CMBI) at Imperial College London, identified SteD, an effector of the Type III Secretion System (T3SS) encoded by Salmonella pathogenicity island 2 (SPI-2), as the first example of a virulence factor that reduces surface-localised mature Major Histocompatibility Complex class II (MHCII) levels in Dendritic Cells. In addition, I have found an increased activation of T cells following infection of C57BL/6 mice with S. enterica serovar Typhimurium (STm) ΔsteD mutant in comparison to wild-type STm, thereby showing that SteD is an important modulator of adaptive immunity in vivo. SteD and/or its gene have a high chance of having therapeutic application. I also have obtained preliminary evidence indicating that SteD has additional functions in the manipulation of antigen-presenting cells. Therefore, I propose to use both the acute and chronic mouse models of Salmonella infection to further characterize the influence of SteD on T cell development. Furthermore, I will investigate the mechanistic and physiological significance of natural variation in the amino acid sequence of SteD among a broad range of S. enterica serovars, including the typhoid fever-causing human-adapted serovars Typhi and Paratyphi. Finally, I will explore the possible use of SteD in new formulations of DNA vaccines. These studies will provide important knowledge for the clinical application of this newly described T3SS effector.


year authors and title journal last update
List of publications.
2019 Ondrej Cerny, David W. Holden
Salmonella SPI-2 type III secretion system-dependent inhibition of antigen presentation and T cell function
published pages: , ISSN: 0165-2478, DOI: 10.1016/j.imlet.2019.01.006
Immunology Letters 2020-01-23
2019 Camilla Godlee, Ondrej Cerny, Charlotte H. Durkin, David W. Holden
SrcA is a chaperone for the Salmonella SPI-2 type three secretion system effector SteD
published pages: 15-25, ISSN: 1350-0872, DOI: 10.1099/mic.0.000732
Microbiology 165/1 2020-01-23

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUPASTED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUPASTED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

PNAIC (2018)

Positive and Negative Asymmetry in Intergroup Contact: Its Impact on Linguistic Forms of Communication and Physiological Responses

Read More  

STRESS-Mums (2019)

Study on TRansition and Exclusion in Society of Single-Mums

Read More  

FrogsInSpace (2019)

From ecology to neurobiology: spatial cognition in rainforest frogs

Read More